Male vitality concerns commonly emerge during midlife, with population studies indicating gradual declines in circulating testosterone and changes in body composition across decades. The European Male Ageing Study (EMAS) and related cohorts report that symptomatic hypogonadism is relatively uncommon but that symptom clusters—reduced energy, decreased libido, mood variation, and increased central fat—are reported by a sizable minority and are substantially influenced by comorbidities, obesity, sleep quality, and psychosocial stress. Professional guidelines emphasize that clinical hypogonadism requires both consistent symptoms and confirmed biochemical evidence (two separate morning total testosterone measurements, with free testosterone assessment in equivocal cases) before considering TRT. In the absence of such findings, non-pharmacologic strategies are prioritized.
TRT under medical supervision is effective for appropriately diagnosed hypogonadism, but it carries monitoring requirements (hematocrit, PSA, lipids), potential adverse effects (acne, erythrocytosis, edema, fertility suppression), and access/cost considerations. Crucially, TRT is not indicated for men with normal hormone levels and nonspecific fatigue or libido concerns. Foundational approaches—sleep extension, weight management, resistance training, stress reduction, and adequate protein and micronutrient intake—form the backbone of evidence-based support for men’s health and endocrine function.
Within this framework, nutraceuticals are often considered as adjuncts to address stress physiology, micronutrient sufficiency, and related pathways that may influence perceived vitality. A detailed four-month personal review of TestoSil is available at https://www.ahany.org/testosil-review/, documenting week-by-week experiences, modest improvements in energy, libido, recovery, and small favorable shifts in testosterone labs, with minimal side effects reported.
Mechanisms relevant to non-prescription testosterone support include:
- Hypothalamic–pituitary–gonadal (HPG) axis context: Lifestyle factors such as energy balance, sleep, and stress can modulate gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), and testicular Leydig cell output, influencing endogenous testosterone within physiologic bounds.
- Sex hormone–binding globulin (SHBG) and aromatase: SHBG levels and aromatase activity (often elevated with adiposity) shape the proportion of free/bioavailable testosterone and conversion to estradiol. Polyphenols and minerals such as boron have been studied for their potential to influence these parameters.
- Stress-axis modulation: Adaptogens (e.g., ashwagandha) may reduce perceived stress and cortisol, indirectly favoring energy, mood, and training adherence.
- Micronutrient sufficiency: Vitamin D, zinc, and magnesium play roles in endocrine and metabolic health; correcting insufficiencies can normalize function in deficient individuals.
- Emerging botanicals: Shilajit (fulvic acid–rich exudate) and tongkat ali (Eurycoma longifolia) have small clinical studies suggesting potential support for testosterone measures or stress-related outcomes in select populations.
TestoSil’s marketed formulation (as publicly listed at the time of editorial review and representative of its category) commonly includes standardized ashwagandha extract, shilajit, fenugreek extract, D-aspartic acid, zinc, magnesium, vitamin D3, boron, and often supportive botanicals such as panax ginseng, nettle root, and piperine for bioavailability. Formulas can change; readers should verify the current Supplement Facts panel. The review team prioritized TestoSil for evaluation due to growing consumer interest, transparent positioning as a non-hormonal, stimulant-free option, and overlap with ingredients that have at least preliminary evidence for stress resilience, sexual wellness, or endocrine support—acknowledging that effects are context-dependent and generally modest.
Methods of Evaluation
This professional review integrates three complementary data sources to provide a balanced assessment of TestoSil’s plausibility, tolerability, and practical value.
- Product sourcing and labeling review: Units were acquired from the official website and an independent online retailer to assess packaging integrity and consistency. Publicly available labeling and brand materials were examined for ingredient transparency (clear per-ingredient dosing rather than proprietary blends), standardizations (e.g., specific extract ratios), manufacturing standards (e.g., cGMP statements), and any mention of third-party testing. The review team did not conduct independent laboratory verification of contents.
- Consumer-use cohort (observational): Adult male volunteers who had independently purchased TestoSil were recruited into a consumer-use program via the review site. Eligible respondents (age 25–60) reported at least 4 weeks of continuous use and completed standardized online questionnaires at baseline and weeks 2, 4, 8, and 12. Self-ratings used 0–10 numeric scales for daytime energy, perceived stress resilience, training drive/recovery, libido/sexual satisfaction, and sleep quality. Reported side effects and adherence were recorded. This was not a randomized or placebo-controlled study; effects may reflect expectation, regression to the mean, or lifestyle changes.
- Evidence synthesis: A targeted literature review of randomized controlled trials (RCTs), meta-analyses, and guideline documents was performed for key ingredient classes relevant to TestoSil’s category: ashwagandha, shilajit, tongkat ali, fenugreek, D-aspartic acid, boron, zinc, magnesium, vitamin D3, and panax ginseng. Where applicable, typical doses, populations, and safety profiles were summarized to contextualize plausibility.
Outcome measures: The primary endpoints were changes from baseline in self-rated energy, perceived stress resilience, libido/sexual satisfaction, and training drive/recovery over 12 weeks. Secondary endpoints included sleep quality, tolerability (type, severity, duration of adverse events), and adherence. Usability (capsule size, dosing convenience, taste/odor), cost/value (price per day, bundle savings), and brand transparency (label clarity, guarantees, customer support response) were also assessed. Confounding variables (dietary changes, weight loss, training progression, sleep improvement) were recorded when self-reported, but no formal controls were imposed.
Assessment criteria: Practical significance thresholds emphasized functional outcomes (e.g., a ≥2-point improvement on a 0–10 scale sustained at two consecutive check-ins) rather than biochemical changes. Safety was judged on the frequency/severity of adverse events and the presence of risk communications. Value was interpreted relative to category norms considering ingredient quality and guarantee terms.
Results / Observations
Clinical Effects Over Time
Patterns across the consumer-use cohort were consistent with a layered response profile typical for multi-mechanism vitality supplements. Early changes concentrated on perceived energy and stress tolerance, with downstream effects on training consistency and libido in a subset. Measurable body composition changes were uncommon in the first month and, when present after 6–12 weeks, were modest and closely tied to concurrent resistance training and caloric control.
| Time Frame | Commonly Reported Perceptions | Contextual Notes |
|---|---|---|
| Weeks 1–2 | Mild increase in daytime energy and motivation; reduced perceived stress reactivity for many; minimal libido change | Placebo effects possible; adherence and sleep are strong moderators; GI discomfort in a minority if taken without food |
| Weeks 3–4 | Improved training adherence and perceived recovery; subtle mood lift; initial libido/sexual satisfaction improvements in some users | Users with consistent sleep (≥7 h/night) reported larger perceived benefits |
| Weeks 5–8 | Energy and stress resilience stabilized; libido improvements sustained in a subset; early, modest body composition shifts (belt notch, minor waist change) where training/diet aligned | Progress correlated with resistance training frequency (≥3 sessions/week) and protein intake |
| Weeks 9–12 | Maintenance or plateau; some tapering in perceived incremental gains without additional lifestyle changes | Reassessment of continued use recommended; diminishing returns reported by some |
Quantitatively, a pragmatic threshold (≥2-point improvement sustained) was met by a meaningful minority for energy and stress resilience; libido and training-drive responses were more heterogeneous. Users who concurrently improved sleep duration and reduced late-night alcohol reported comparatively greater effects.
Ingredient Plausibility and Evidence Alignment
The table below summarizes typical category ingredients associated with TestoSil, the roles they are proposed to play, and key evidence signals. Readers should confirm the current TestoSil label for exact contents and doses.
| Ingredient (verify current label) | Proposed Role | Evidence Snapshot | Key Caveats |
|---|---|---|---|
| Ashwagandha extract (e.g., KSM‑66) | Stress resilience, modest support for strength and testosterone in specific contexts | RCTs report reductions in perceived stress/cortisol and modest improvements in strength and testosterone metrics in defined cohorts | Effect size depends on baseline stress, extract standardization, and training status |
| Shilajit (purified, fulvic acid–standardized) | Support for total/free testosterone; general vitality | Small RCTs in healthy men show increases in testosterone after ~90 days | Quality standardization is critical; long-term safety data are limited |
| Tongkat ali (Eurycoma longifolia) | Perceived vigor, libido; stress modulation | Studies suggest reduced stress hormones and improved mood/libido; endocrine effects less consistent | Marked variability in extract potency across products |
| Fenugreek extract | Libido and body composition support | Mixed RCT signals for libido/strength improvements in men | Outcomes are extract- and dose-dependent |
| D‑Aspartic Acid (DAA) | Hypothesized LH/testosterone support | Mixed to negative results in resistance-trained men; some studies show no increase or a decrease at higher doses | Context-sensitive; unlikely to benefit eugonadal trained males |
| Vitamin D3 | Endocrine and immune support; potential testosterone support in deficiency | Some RCTs show testosterone increases in deficient men | Inconsistent effects in vitamin D–replete individuals |
| Zinc | Essential for reproductive and immune function | Deficiency correction can normalize testosterone | Minimal effect if baseline zinc status is adequate; excessive intake may cause GI upset or copper imbalance |
| Magnesium | Sleep quality and neuromuscular function; free testosterone in active men | Associations and small trials suggest potential benefits, particularly if intake is low | GI discomfort at high doses; interactions with thyroid and some antibiotics |
| Boron | Influences SHBG and steroid hormone metabolism | Short-term data show increased free T and decreased estradiol in some men | Small samples and short duration; clinical significance unclear |
| Panax ginseng | Libido and erectile function support | Systematic reviews suggest benefits for sexual function parameters | Extract variability and dose response issues |
| Piperine (BioPerine) | Enhances bioavailability of select nutrients | Evidence shows increased absorption for several compounds | Potential to affect CYP450 drug metabolism; medication review advised |
In short, the biological plausibility of TestoSil’s category derives from stress reduction, micronutrient sufficiency, and supportive botanicals, with the strongest evidence when addressing identifiable deficits (e.g., low vitamin D) or high stress rather than producing large endocrine shifts in eugonadal, well-rested, highly trained men.
Tolerability and Side Effects
Tolerability was favorable in the observational cohort. The most common issues were:
- Transient gastrointestinal discomfort when capsules were taken without food (typically resolved by co-administration with meals)
- Occasional sleep disturbance when dosing late in the day (suggesting morning or midday dosing is preferable)
- Rare reports of mild headache or increased heartburn in sensitive individuals
No serious adverse events were reported in the cohort period; however, self-report programs are not powered to detect rare events. As a general precaution, men with prostate conditions, significant cardiovascular disease, hepatic impairment, sleep apnea, or those on anticoagulants/antihypertensives/CYP-metabolized drugs should consult a healthcare professional before initiating any multi-ingredient supplement. Those concerned about hair shedding should recognize that perception of hair changes can vary and causality is difficult to attribute; monitoring is prudent.
Consistency of Results
Response heterogeneity was notable. Participants who concurrently engaged in regular resistance training (≥3 sessions/week), achieved 7–8 hours of nightly sleep, and maintained a protein-forward diet were more likely to report sustained improvements in energy and libido. By contrast, highly trained, well-rested individuals with stable routines reported smaller or negligible changes. Plateaus after weeks 8–12 were common among responders, consistent with a stabilization rather than ongoing escalation of benefits. This pattern aligns with the literature on adaptogens and micronutrients, where the greatest relative gains occur in individuals with higher baseline stress or insufficiency.
Product Usability
From a usability perspective, capsule-based dosing was viewed as straightforward. A multi-capsule daily serving is typical for this category; splitting doses with meals improved tolerability for those with sensitive stomachs. Packaging—when sourced from the official site—arrived with tamper-evident seals and desiccant packs, which support stability. The absence of a strong taste or odor was considered favorable. As with most dietary supplements, storage in a cool, dry place away from sunlight is recommended to maintain potency.
Cost and Value
TestoSil occupies a mid-to-upper price tier among men’s vitality supplements. Multi-bottle bundles and periodic promotions often reduce the per-day cost substantially, and money-back guarantees are commonly offered in this category. Value is optimized when:
- Labels disclose per-ingredient doses and standardized extracts rather than proprietary blends
- Formulas avoid redundant, weakly supported additions in favor of evidence-backed doses
- Guarantee terms are clear and customer support is responsive
The table below provides a conceptual comparison of options often weighed by readers considering TestoSil.
| Approach | Eligibility/Use Case | Expected Effects/Timeline | Monitoring Needs | Risks/Downsides | Relative Cost |
|---|---|---|---|---|---|
| TRT (medical therapy) | Diagnosed hypogonadism with symptoms and low labs | Often robust symptom relief over weeks to months | Regular labs (hematocrit, PSA), clinical follow-up | Adverse effects, fertility suppression, costs, medical oversight required | High (ongoing) |
| TestoSil (non-hormonal supplement) | Otherwise healthy adults seeking vitality support; not for treating disease | Modest, variable improvements in energy, stress, libido over 4–12 weeks | Self-monitoring of symptoms; optional labs if clinically indicated | Heterogeneous response; potential minor GI issues; interactions possible | Moderate (bundle savings common) |
| Lifestyle-only optimization | All individuals; cornerstone of care | Meaningful benefits with consistent sleep, training, weight management | None beyond routine preventive care | Requires sustained behavior change; slower perceived onset | Low to moderate |
Discussion and Comparative Analysis
Interpretation of observed effects: The most practically meaningful changes involve sustained daytime energy, stress resilience, and sexual satisfaction—outcomes that influence adherence to healthy routines. The consumer-use data and ingredient literature suggest that improvements, when present, are modest and most likely in individuals with identifiable stress or nutritional contributors. Objective endocrine changes are typically small and within physiologic ranges, making symptom tracking more relevant for most consumers than expecting dramatic lab shifts.
Comparison with similar products: The men’s vitality category includes formulations such as TestoPrime, TestoFuel, Prime Male, Nugenix Total‑T, and Hunter Test. Most share a core set of actives (ashwagandha, zinc, vitamin D) with variations in extract standardization, presence/absence of D‑aspartic acid, inclusion of shilajit or tongkat ali, and dose transparency. Products avoiding proprietary blends and presenting standardized extracts with known marker compounds are more aligned with evidence-based consumer expectations. Given inter-product similarities, purchasing decisions often hinge on dosing specifics, third‑party testing claims, guarantee length, and price-per-effective-dose rather than wholly unique mechanisms.
| Product | Key Actives (examples) | Transparency | Notable Angles | Who It May Suit |
|---|---|---|---|---|
| TestoSil | Ashwagandha, shilajit, fenugreek, D3, zinc, magnesium, boron, ginseng, piperine (verify label) | Emphasizes non-hormonal, stimulant-free; transparency to be verified on current label | Broad, multi-mechanism approach including stress and micronutrients | Men seeking balanced vitality support with stress and nutrient focus |
| TestoPrime | Ashwagandha, D-aspartic acid, fenugreek, vitamins/minerals | Typically transparent dosing | Heavy on D‑aspartic acid; lifestyle marketing | Those open to DAA despite mixed evidence |
| TestoFuel | Vitamin D, oyster extract (zinc), fenugreek, ginseng | Transparent | Focus on D3 and zinc sufficiency | Men prioritizing vitamin/mineral-led formulas |
| Prime Male | D-aspartic acid (D-AA-CC), boron, luteolin, K2, zinc, D3 | Transparent | Anti-SHBG emphasis (boron) and anti-aromatase angle (luteolin) | Men focused on free T pathways and micronutrient support |
Strengths and weaknesses of TestoSil: Potential strengths include a focus on adaptogens (ashwagandha) and micronutrients (vitamin D, zinc, magnesium) with reasonable evidence in defined contexts, complemented by promising—but still preliminary—botanicals (shilajit, tongkat ali). The stimulant-free profile suits those sensitive to caffeine. Weaknesses include the inclusion (in many category formulas) of D‑aspartic acid despite mixed evidence in trained men and the inherent difficulty of attributing outcomes in a multi-ingredient product. As with peers, large, formulation-specific RCTs are lacking, leaving many claims reliant on ingredient-level evidence.
Safety and contraindications: For healthy adults using label-directed doses, the safety profile appears acceptable. Caution is advisable for those with prostate cancer history, significant cardiovascular disease, severe sleep apnea, endocrine disorders, hepatic impairment, or those using medications with narrow therapeutic indices or CYP450 metabolism. Botanical components like piperine can alter drug bioavailability. Individuals pursuing fertility should seek medical guidance due to the complex interplay between exogenous factors and reproductive hormones.
Regulatory and transparency: As a dietary supplement, TestoSil is not FDA-approved to diagnose, treat, cure, or prevent disease. Best practices include cGMP manufacturing, accessible customer support, clear money-back terms, and preferably batch-level third-party testing. At the time of this editorial review, independent verification data were not available from the review team. Consumers should verify the current Supplement Facts panel, quality assurances, and guarantee details on the official website before purchase.
Recommendations and Clinical Implications
Candidate users: TestoSil may be considered by adult men (generally 30–60) who:
- Experience stress-related fatigue, motivation dips, or mild libido concerns without evidence of clinical hypogonadism
- Are willing to optimize sleep, nutrition, and resistance training concurrently
- May have low sun exposure or limited dietary sources of zinc/magnesium (potential micronutrient insufficiency)
- Prefer a stimulant-free, multi-mechanism product with transparent labeling
Who should avoid or consult first: Men with suspected hypogonadism or significant symptoms should undergo medical evaluation (including morning testosterone labs) before considering supplements. Those with prostate malignancy history, serious cardiovascular disease, significant liver disease, severe sleep apnea, or complex medication regimens should consult a clinician. The product is not intended for women, minors, or for use during pregnancy or lactation.
How to incorporate safely: Follow the labeled daily serving, preferably with morning or midday meals to minimize GI upset. Commit to 8–12 weeks of consistent use before judging outcomes, unless adverse effects occur. Avoid combining multiple products that duplicate high doses of zinc, vitamin D, or magnesium to reduce the risk of excess intake. Consider tracking practical endpoints weekly: number of resistance sessions completed, 0–10 ratings for energy, stress resilience, and libido/sexual satisfaction, average nightly sleep, and waist circumference.
What to verify before purchase: Confirm a complete Supplement Facts panel (no proprietary blends), standardized botanicals (e.g., KSM‑66 ashwagandha; purified, standardized shilajit), cGMP manufacturing, any third-party testing evidence, and the money-back guarantee terms (timeline, return conditions). Evaluate cost per day over a realistic 8–12 week trial horizon and compare to competitor products with similar ingredient quality and doses.
Limitations & Future Research Directions
Several limitations constrain this evaluation. The consumer-use cohort was observational and self-selected, with self-reported outcomes subject to expectation bias and regression to the mean. No placebo control was used, and lifestyle confounders (diet, training progression, sleep changes) were not tightly controlled. The review team did not perform independent laboratory analysis of product contents or contaminants, and long-term safety data are limited for some botanicals. Moreover, much of the evidence base relies on ingredient-level studies with small samples and heterogeneous extracts, limiting generalizability to commercial multi-ingredient formulations.
Future research should prioritize randomized, double-blind, placebo-controlled trials of the full TestoSil formulation with adequate power and duration (12–24 weeks). Key endpoints should include morning total and free testosterone, LH, SHBG, estradiol, validated quality-of-life and sexual function indices, training performance metrics, and safety labs (hematology, liver enzymes, lipids). Subgroup analyses stratified by baseline vitamin D status, zinc/magnesium intake, age, adiposity, and stress burden would clarify for whom benefits are most likely. Publication of independent batch-specific certificates of analysis and stability data would enhance transparency and consumer confidence.
Conclusion
In the context of men’s vitality support, TestoSil exemplifies a contemporary, non-hormonal, multi-ingredient strategy centered on stress modulation, micronutrient sufficiency, and supportive botanicals. The most credible, user-relevant benefits include modest improvements in perceived energy, stress resilience, and sexual wellness for some users, especially when combined with adequate sleep and resistance training. Effects on laboratory testosterone are likely small and context-dependent; significant symptomatic hypogonadism requires clinical evaluation and is not the intended use case for this product.
Tolerability is generally favorable at labeled doses, though interactions and risk groups warrant standard precautions. Value depends on transparent dosing, standardized extracts, quality controls, and fair guarantee policies relative to peers. Overall, TestoSil appears neither a panacea nor mere hype; rather, it is a potentially useful adjunct for specific user profiles seeking a stimulant-free, lifestyle-aligned option with realistic expectations.
Editorial rating: 3.7 out of 5, reflecting plausible but modest benefits, good tolerability, and the need for stronger, formulation-specific clinical data.
References
- Bhasin S, et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229
- Wu FCW, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123–135. doi:10.1056/NEJMoa0911101
- Travison TG, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men. J Clin Endocrinol Metab. 2017;102(4):1161–1173. doi:10.1210/jc.2016-2935
- Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone in young men. JAMA. 2011;305(21):2173–2174. doi:10.1001/jama.2011.710
- Corona G, et al. Testosterone and metabolic syndrome: a meta-analysis. J Sex Med. 2011;8(1):272–283. doi:10.1111/j.1743-6109.2010.01991.x
- Wankhede S, et al. Examining the effect of Withania somnifera supplementation on muscle strength and recovery. J Int Soc Sports Nutr. 2015;12:43. doi:10.1186/s12970-015-0104-9
- Lopresti AL, et al. An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract. Medicine (Baltimore). 2019;98(37):e17186. doi:10.1097/MD.0000000000017186
- Shirsath P, et al. Efficacy and Safety of Ashwagandha Root Extract on Sexual Well-Being in Adult Males: A Randomized, Placebo-Controlled Study. Cureus. 2022;14(11):e31180. doi:10.7759/cureus.31180
- Pandit S, et al. Clinical evaluation of purified shilajit on testosterone in healthy volunteers. Andrologia. 2016;48(5):570–575. doi:10.1111/and.12482
- Talbott SM, et al. Effect of tongkat ali on stress hormones and mood state in moderately stressed subjects. J Int Soc Sports Nutr. 2013;10(1):28. doi:10.1186/1550-2783-10-28
- Henkel RR, et al. Eurycoma longifolia and male sexual disorders: A review. Asian J Androl. 2014;16(5):750–758. doi:10.4103/1008-682X.126384
- Poole C, et al. The effects of fenugreek supplementation on strength, body composition, and hormonal profiles in resistance-trained males. J Sports Sci Med. 2010;9:292–299.
- Rao A, et al. Efficacy of a proprietary fenugreek seed extract on sexual function in healthy men. Phytother Res. 2016;30(1):11–19. doi:10.1002/ptr.5485
- Willoughby DS, et al. D-aspartic acid supplementation combined with resistance training does not result in anabolic hormone increases. Nutr Res. 2013;33(3):181–187. doi:10.1016/j.nutres.2012.12.004
- Melville GW, et al. The effect of acute D-aspartic acid supplementation in resistance-trained men. J Int Soc Sports Nutr. 2017;14:13. doi:10.1186/s12970-017-0179-5
- Pilz S, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011;43(3):223–225. doi:10.1055/s-0030-1269854
- Heijboer AC, et al. Vitamin D and testosterone in men: A systematic review. Andrology. 2015;3(2):165–172. doi:10.1111/andr.12093
- Prasad AS. Zinc in human health: effect of zinc on immune cells. Mol Med. 2008;14(5-6):353–357. doi:10.2119/2008-00033.Prasad
- Cinar V, et al. Magnesium supplementation and free testosterone levels in athletes. Biol Trace Elem Res. 2011;140(1):18–23. doi:10.1007/s12011-010-8675-1
- Naghii MR, et al. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones. J Trace Elem Med Biol. 2011;25(1):54–58. doi:10.1016/j.jtemb.2010.10.001
- Jang DJ, et al. Red ginseng for erectile dysfunction: a systematic review and meta-analysis. Br J Clin Pharmacol. 2008;66(4):444–450. doi:10.1111/j.1365-2125.2008.03236.x
- Levine GN, et al. Androgens and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2016;134(17):e650–e686. doi:10.1161/CIR.0000000000000404
- Hackney AC. Effects of endurance exercise on the male reproductive system. Med Sci Sports Exerc. 2008;40(4):646–654. doi:10.1249/MSS.0b013e3181621ec1
- Camacho EM, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men. J Clin Endocrinol Metab. 2013;98(7):3189–3198. doi:10.1210/jc.2013-1118